Literature DB >> 20634487

Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy.

Andreas Stahl1, Przemyslaw Sapieha, Kip M Connor, John Paul Sangiovanni, Jing Chen, Christopher M Aderman, Keirnan L Willett, Nathan M Krah, Roberta J Dennison, Molly R Seaward, Karen I Guerin, Jing Hua, Lois E H Smith.   

Abstract

RATIONALE: Omega3 long-chain polyunsaturated fatty acids (omega3-PUFAs) are powerful modulators of angiogenesis. However, little is known about the mechanisms governing omega3-PUFA-dependent attenuation of angiogenesis.
OBJECTIVE: This study aims to identify a major mechanism by which omega3-PUFAs attenuate retinal neovascularization. METHODS AND
RESULTS: Administering omega3-PUFAs exclusively during the neovascular stage of the mouse model of oxygen-induced retinopathy induces a direct neovascularization reduction of more than 40% without altering vasoobliteration or the regrowth of normal vessels. Cotreatment with an inhibitor of peroxisome proliferator-activated receptor (PPAR)gamma almost completely abrogates this effect. Inhibition of PPARgamma also reverses the omega3-PUFA-induced reduction of retinal tumor necrosis factor-alpha, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial selectin, and angiopoietin 2 but not vascular endothelial growth factor.
CONCLUSIONS: These results identify a direct, PPARgamma-mediated effect of omega3-PUFAs on retinal neovascularization formation and retinal angiogenic activation that is independent of vascular endothelial growth factor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634487      PMCID: PMC2975617          DOI: 10.1161/CIRCRESAHA.110.221317

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

Review 1.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

Review 2.  Angiopoietins: a link between angiogenesis and inflammation.

Authors:  Ulrike Fiedler; Hellmut G Augustin
Journal:  Trends Immunol       Date:  2006-10-12       Impact factor: 16.687

3.  Response of experimental retinal neovascularization to thiazolidinediones.

Authors:  T Murata; Y Hata; T Ishibashi; S Kim; W A Hsueh; R E Law; D R Hinton
Journal:  Arch Ophthalmol       Date:  2001-05

4.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

5.  Rosiglitazone and delayed onset of proliferative diabetic retinopathy.

Authors:  Lucy Q Shen; Angie Child; Griffin M Weber; Judah Folkman; Lloyd Paul Aiello
Journal:  Arch Ophthalmol       Date:  2008-06

6.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.

Authors:  Kip M Connor; Nathan M Krah; Roberta J Dennison; Christopher M Aderman; Jing Chen; Karen I Guerin; Przemyslaw Sapieha; Andreas Stahl; Keirnan L Willett; Lois E H Smith
Journal:  Nat Protoc       Date:  2009-10-08       Impact factor: 13.491

Review 7.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

8.  Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.

Authors:  Kip M Connor; John Paul SanGiovanni; Chatarina Lofqvist; Christopher M Aderman; Jing Chen; Akiko Higuchi; Song Hong; Elke A Pravda; Sharon Majchrzak; Deborah Carper; Ann Hellstrom; Jing X Kang; Emily Y Chew; Norman Salem; Charles N Serhan; Lois E H Smith
Journal:  Nat Med       Date:  2007-06-24       Impact factor: 53.440

9.  Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis.

Authors:  A Stratmann; W Risau; K H Plate
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Omega-3 Fatty Acids and PPARgamma in Cancer.

Authors:  Iris J Edwards; Joseph T O'Flaherty
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more
  51 in total

Review 1.  Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.

Authors:  Andreas Stahl; Tim U Krohne; Przemyslaw Sapieha; Jing Chen; Ann Hellstrom; Emily Chew; Frank G Holz; Lois E H Smith
Journal:  Br J Ophthalmol       Date:  2011-03-18       Impact factor: 4.638

2.  Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.

Authors:  Zhongjie Fu; Chatarina A Lofqvist; Zhuo Shao; Ye Sun; Jean-Sebastien Joyal; Christian G Hurst; Ricky Z Cui; Lucy P Evans; Katherine Tian; John Paul SanGiovanni; Jing Chen; David Ley; Ingrid Hansen Pupp; Ann Hellstrom; Lois E H Smith
Journal:  Am J Clin Nutr       Date:  2015-02-04       Impact factor: 7.045

Review 3.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  [Pharmacological treatment for retinopathy of prematurity].

Authors:  A Stahl; H Agostini; C Jandeck; W Lagrèze
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

5.  Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism.

Authors:  Kechen Ban; Julie M Sprunt; Stephanie Martin; Peiying Yang; Rosemary A Kozar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-07       Impact factor: 4.052

6.  Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.

Authors:  Zhuo Shao; Zhongjie Fu; Andreas Stahl; Jean-Sébastien Joyal; Colman Hatton; Aimee Juan; Christian Hurst; Lucy Evans; Zhenghao Cui; Dorothy Pei; Yan Gong; Dan Xu; Katherine Tian; Hannah Bogardus; Matthew L Edin; Fred Lih; Przemyslaw Sapieha; Jing Chen; Dipak Panigrahy; Ann Hellstrom; Darryl C Zeldin; Lois E H Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

7.  Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.

Authors:  Yan Gong; Zhongjie Fu; Matthew L Edin; Chi-Hsiu Liu; Zhongxiao Wang; Zhuo Shao; Thomas W Fredrick; Nicholas J Saba; Peyton C Morss; Samuel B Burnim; Steven S Meng; Fred B Lih; Kin Sing Stephen Lee; Elizabeth P Moran; John Paul SanGiovanni; Ann Hellström; Bruce D Hammock; Darryl C Zeldin; Lois E H Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

Review 8.  ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.

Authors:  Yan Gong; Zhongjie Fu; Raffael Liegl; Jing Chen; Ann Hellström; Lois Eh Smith
Journal:  Am J Clin Nutr       Date:  2017-05-17       Impact factor: 7.045

9.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

Review 10.  Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.

Authors:  Mayur Choudhary; Goldis Malek
Journal:  J Biomol Screen       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.